Yesterday, Regulus Therapeutics Inc (NASDAQ:RGLS) disclosed unpleasant updates regarding the company’s pipeline. The drug maker announced three program discontinuations, which include drugs: RG-101, a …
After a 200% rally in less than a month, Akari Therapeutics PLC (ADR) (NASDAQ:AKTX) shares tumbled nearly 15% today. The reason?
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) are currently plummeting 62% in pre-market trading after yesterday’s announcement that the biotech firm has discontinued all of its …
In a research report released Friday, Chardan analyst Madhu Kumar upgraded shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) to a Neutral rating, without providing a price …
In a research report released Friday, Chardan analyst Madhu Kumar reiterated a Sell rating on shares of Arbutus Biopharma Corp (NASDAQ:ABUS), after the company …
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) shares are up nearly 6% as of this writing, after the RNAi therapeutics company announced a collaboration with Amgen (NASDAQ:AMGN) …
This morning, Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) announced the initiation of its Phase II trial for its pipeline drug ARC-AAT, a RNAi based investigational …
Shares of Regulus Therapeutics Inc (NASDAQ:RGLS) tumbled 11% today, following the news that the company had received written communication from the FDA requesting additional safety analyses …
